Skip to content

Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial

Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00717691
Enrollment
50
Registered
2008-07-17
Start date
2008-07-31
Completion date
2008-12-31
Last updated
2012-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Limitus

Keywords

Hallux Limitus, Dynamic Splinting, Dynasplint

Brief summary

The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.

Detailed description

Determine the efficacy of dynamic splinting in treating patients with hallux limitus, in a randomized, controlled trial.

Interventions

DEVICEMetatarsophalangeal Extension Dynasplint System

Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn for 30 minutes, three times per day, (while seated or resting in bed) totaling 1.5 hours per day.

OTHERStandard of Care

The current standard of care in treating Hallux Limitus will be given to all patients regardless of randomized categorization, and this includes: analgesic and nonsteroidal anti-inflammatory drugs (NSAIDs), orthotics with medial stiffness, and reduction of great toe movement in motions such as kneeling or squatting with the toes in an extended position.

Sponsors

Dynasplint Systems, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Reduced flexibility in AROM of extension in the great toe * Pain that is worsened by walking and/or squatting * Impaired gait pattern

Exclusion criteria

* Metatarsal stress fracture * Interdigital neuroma * Sesamoid pathology * Gout * Metatarsalgia

Design outcomes

Primary

MeasureTime frame
Change in Active Range of Motion of Hallux (great toe) ExtensionTwo Months

Secondary

MeasureTime frame
Change in passive Range of Motion, Extensionsame

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026